Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Abstract Background Locally advanced or metastatic adenocarcinoma of the pancreas remains - despite the implementation of new chemotherapy protocols - a disease with short overall survival (OS). Methods Eighty-three patients were treated with locally advanced or metastatic adenocarcinoma of the panc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ursula M. Vogl, Haleh Andalibi, Alexander Klaus, Laurenz Vormittag, Wolfgang Schima, Bettina Heinrich, Alice Kafka, Thomas Winkler, Leopold Öhler
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2019-01-01
Colecção:BMC Cancer
Assuntos:
Pancreatic cancer
FOLFIRINOX
Nab-paclitaxel
Gemcitabine
Acesso em linha:http://link.springer.com/article/10.1186/s12885-018-5240-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados